Title : Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.

Pub. Date : 1997 Aug 1

PMID : 9242550






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 T-RA is an effective inducer of clinical remission only in patients carrying the t(15;17) and expressing the PML/RAR alpha products. Tretinoin PML nuclear body scaffold Homo sapiens
2 Moreover, two different high-affinity 9-cis-RA binding sites (Kd = 0.45 and 0.075 nmol/L) were detectable in the bcr3-PML/RAR alpha product but not in the bcr1-PML/RAR alpha product (Kd = 0.77 nmol/L). Tretinoin PML nuclear body scaffold Homo sapiens
3 Moreover, two different high-affinity 9-cis-RA binding sites (Kd = 0.45 and 0.075 nmol/L) were detectable in the bcr3-PML/RAR alpha product but not in the bcr1-PML/RAR alpha product (Kd = 0.77 nmol/L). Tretinoin PML nuclear body scaffold Homo sapiens
4 By competition binding experiments we showed that 9-cis-RA binds with higher specificity to the bcr3-PML/RAR alpha isoform than to the bcr1-PML/RAR alpha or RAR alpha. Tretinoin PML nuclear body scaffold Homo sapiens
5 These results provide evidence indicating that preferential retinoid binding to the different PML/RAR alpha products can be measured. Retinoids PML nuclear body scaffold Homo sapiens